Thermo Fisher Scientific, the world leader in serving science, announced it would host an informative webinar to garner knowledge about the Covid-19 solutions. Thermo Fisher is at the heart of the global response to Covid-19. We are working with government agencies and researchers to ensure priority access to instruments, consumables, safety supplies and other products to address the outbreak–particularly in the analysis of the virus, diagnosis and personal protection.
Thermo Fisher invites customers, whether they’re emerging biotech developing a rare disease therapy, or a high-volume pharmaceutical manufacturer, to learn more about products and technologies for rapid pathogen detection and accelerating vaccine development and manufacturing. This webinar would also be valuable for academicians, industry researchers and diagnostic laboratories.
Comprehensive solutions from detection to vaccine research and manufacturing
The panel will include the following participants from Thermo Fisher – Amit Chopra, managing director, India and Middle East; Savita Bhosekar, scientific support manager, Life Sciences Solutions; Rajesh Bhagwat, general manager, Bioproduction, Life Sciences Solutions; and Sangeeta Thatai, product specialist lead, Biosciences.
“Our portfolio offers capabilities ranging from pathogen detection, epidemiological studies and potential vaccine development to supporting clinical trials and contract development and manufacturing needs of pharma and biotech companies, and more. Our Mission is to enable our customers to make the world healthier, cleaner and safer, and the Covid-19 outbreak is a powerful reminder of the importance of that mission,” Chopra said.
This webinar claims to will offer insights on our workflows by combining capabilities across Thermo Fisher to deliver products faster, with high quality and improved consistency. The live webinar is exclusive to India and is scheduled for 13 May 2020 at 11:30 am IST.
Register for the webinar by clicking here.